Acción 300363 PORTON PHARMA SOLUTIONS LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Porton Pharma Solutions Ltd.

Acciones

300363

CNE100001S57

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
16,81 CNY -1,70 % Gráfico intradía de Porton Pharma Solutions Ltd. +3,32 % -33,16 %
26/04 Porton Pharma Solutions Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
26/04 Porton Pharma Solutions Ltd. Resultados del ejercicio finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility
China’s Porton to set up biotech park in Slovenia’s Menges
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300363
  4. Noticias Porton Pharma Solutions Ltd.
  5. Otros idiomas